JP2001517984A - 吸入装置 - Google Patents
吸入装置Info
- Publication number
- JP2001517984A JP2001517984A JP54043198A JP54043198A JP2001517984A JP 2001517984 A JP2001517984 A JP 2001517984A JP 54043198 A JP54043198 A JP 54043198A JP 54043198 A JP54043198 A JP 54043198A JP 2001517984 A JP2001517984 A JP 2001517984A
- Authority
- JP
- Japan
- Prior art keywords
- inhaler
- mouthpiece
- air
- chamber
- inhaler according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 claims abstract description 139
- 238000009825 accumulation Methods 0.000 claims abstract description 22
- 230000002093 peripheral effect Effects 0.000 claims description 57
- 230000000153 supplemental effect Effects 0.000 claims description 24
- 241000257465 Echinoidea Species 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 2
- 238000007654 immersion Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 32
- 230000004048 modification Effects 0.000 description 31
- 238000012986 modification Methods 0.000 description 31
- 229940079593 drug Drugs 0.000 description 23
- 238000005192 partition Methods 0.000 description 15
- 230000007246 mechanism Effects 0.000 description 10
- 239000002245 particle Substances 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- -1 Limiterol Chemical compound 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002220 antihypertensive agent Substances 0.000 description 3
- 229940030600 antihypertensive agent Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 2
- NUBLQEKABJXICM-FQEVSTJZSA-N (1r)-1-(4-amino-3,5-dichlorophenyl)-2-[6-(2-pyridin-2-ylethoxy)hexylamino]ethanol Chemical compound C1=C(Cl)C(N)=C(Cl)C=C1[C@@H](O)CNCCCCCCOCCC1=CC=CC=N1 NUBLQEKABJXICM-FQEVSTJZSA-N 0.000 description 2
- PDNHLCRMUIGNBV-UHFFFAOYSA-N 1-pyridin-2-ylethanamine Chemical compound CC(N)C1=CC=CC=N1 PDNHLCRMUIGNBV-UHFFFAOYSA-N 0.000 description 2
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 2
- 108010001857 Cell Surface Receptors Proteins 0.000 description 2
- 102000009025 Endorphins Human genes 0.000 description 2
- 108010049140 Endorphins Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102100037611 Lysophospholipase Human genes 0.000 description 2
- 108010058864 Phospholipases A2 Proteins 0.000 description 2
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000048 adrenergic agonist Substances 0.000 description 2
- 229940126157 adrenergic receptor agonist Drugs 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000001078 anti-cholinergic effect Effects 0.000 description 2
- 239000000043 antiallergic agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000003096 antiparasitic agent Substances 0.000 description 2
- 229940125687 antiparasitic agent Drugs 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 2
- 229940092705 beclomethasone Drugs 0.000 description 2
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 description 2
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 2
- 229960002537 betamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- JBRBWHCVRGURBA-UHFFFAOYSA-N broxaterol Chemical compound CC(C)(C)NCC(O)C1=CC(Br)=NO1 JBRBWHCVRGURBA-UHFFFAOYSA-N 0.000 description 2
- 229950008847 broxaterol Drugs 0.000 description 2
- 229960004436 budesonide Drugs 0.000 description 2
- 108010015046 cell aggregation factors Proteins 0.000 description 2
- 229960001117 clenbuterol Drugs 0.000 description 2
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 229960000265 cromoglicic acid Drugs 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 229960001022 fenoterol Drugs 0.000 description 2
- 229940043075 fluocinolone Drugs 0.000 description 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 2
- 229960002714 fluticasone Drugs 0.000 description 2
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 2
- 229960002848 formoterol Drugs 0.000 description 2
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- SYCWERNQGSKYAG-QVRIGTRMSA-N hydron;8-hydroxy-5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]-1h-quinolin-2-one;chloride Chemical compound Cl.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C2=C1C=CC(=O)N2 SYCWERNQGSKYAG-QVRIGTRMSA-N 0.000 description 2
- 229960001361 ipratropium bromide Drugs 0.000 description 2
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 description 2
- 229960001317 isoprenaline Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000003199 leukotriene receptor blocking agent Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- JSJCTEKTBOKRST-UHFFFAOYSA-N mabuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(C(F)(F)F)=C1 JSJCTEKTBOKRST-UHFFFAOYSA-N 0.000 description 2
- 229950004407 mabuterol Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 102000006240 membrane receptors Human genes 0.000 description 2
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 description 2
- 230000000510 mucolytic effect Effects 0.000 description 2
- 229940066491 mucolytics Drugs 0.000 description 2
- 229960002259 nedocromil sodium Drugs 0.000 description 2
- 229960002657 orciprenaline Drugs 0.000 description 2
- 239000000813 peptide hormone Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 229960002720 reproterol Drugs 0.000 description 2
- WVLAAKXASPCBGT-UHFFFAOYSA-N reproterol Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CCCNCC(O)C1=CC(O)=CC(O)=C1 WVLAAKXASPCBGT-UHFFFAOYSA-N 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 229960004017 salmeterol Drugs 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 229960000195 terbutaline Drugs 0.000 description 2
- 229960002117 triamcinolone acetonide Drugs 0.000 description 2
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000005538 withdrawn drug Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
- A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
- A61M15/0008—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/007—Mechanical counters
- A61M15/0071—Mechanical counters having a display or indicator
- A61M15/0076—Mechanical counters having a display or indicator on a drum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Nozzles (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Manipulator (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.吸入によって散薬を投与する吸入器において、 複数の面によって形成され、マウスピース(2)を有し、使用時にユーザの吸 入によって空気の流れが引き込まれる流路と、 該流路に1服用分の散薬を与えて空気の流れに浮遊させる投与手段(8)とか らなり、 前記投与手段(18)の下流に、該投与手段(18)の下流側の前記流路の面 に散薬が蓄積するのを抑制する移動可能部材をさらに有することを特徴とする吸 入器。 2.前記流路は、入口と出口を有する室(58)を有する請求項1に記載の吸入 器。 3.前記移動可能部材は、前記室(58)の入口を通って引き込まれる空気の流 れを遮るものであり、当該空気の流れによって少なくとも部分的に移動可能であ る請求項2に記載の吸入器。 4.前記移動可能部材は、回転可能部材であり、該回転可能部材は、前記室(5 8)の中で軸の周りに回転可能であり、前記室(58)の入口と対向して配置さ れ、使用時に移動面を与えて、前記室(58)の入口を通して引き込まれる散薬 を含む空気の流れが当該移動面に向かうようにした請求項3に記載の吸入器。 5.前記回転可能部材は、少なくとも1つの要素を有し、該要素に、ユーザの吸 引により前記室(58)の入口を通して引き込まれる空気の流れが作用して、前 記回転可能部材の回転を引き起こすようにした請求項4に記載の吸入器。 6.前記回転可能部材は、複数の傾斜アーム(64)を有するディスク(62) からなる請求項5に記載の吸入器。 7.前記傾斜アーム(64)は、前記室(58)の入口と出口の間に真っ直ぐな 流路を与えないように形成されている請求項6に記載の吸入器。 8.前記回転可能部材は、少なくとも1つの螺旋状突起(81;116)が中に 配設された管状部(79;114)と、前記室(58)の1つの面を形成する半 径方向外方に延びるフランジ(83;118)とからなる請求項5に記載の吸入 器。 9.前記フランジ(83;118)は、前記室(58)の入口に対向して配置さ れている請求項8に記載の吸入器。 10.前記室(58)の入口に対向するフランジ(83;118)の1つの面は 、起伏面からなる請求項9に記載の吸入器。 11.前記起伏面(92)は、整列した凹部(94)からなる請求項10に記載 の吸入器。 12.前記起伏面(92)は、整列した凸部(94)からなる請求項10に記載 の吸入器。 13.前記マウスピース(2)は、ユーザの唇によって把持される第1の外側部 (48)と、該外側部の中に配置された第2の内側部(70;112)とからな り、 前記回転可能部材は、内側部(70;112)を有し、 前記フランジ(83;118)の下面(86;119)は、前記室(58)の 上面を形成している請求項8から12のいずれかに着四阿の吸入器。 14.前記フランジ(83;118)の外周面(82;129)は、前記マウス ピース(2)の外側部(48)の内周面(85)と摺動可能に嵌合している請求 項13に記載の吸入器。 15.前記フランジ(83;118)は、下方に垂下する周縁スカート(80; 128)を有し、該スカートは当該フランジ(83;118)の外周面(82; 129)を形成している請求項14に記載の吸入器。 16.前記マウスピース(2)の外側部(48)は、中央スピンドル(72)を 有し、該スピンドルの周りにマウスピース(2)の内側部(70)が回転可能に 装着されている請求項13から15のいずれかに記載の吸入器。 17.前記マウスピース(2)の外側部(48)は、環状スリーブ(120)を 有し、該環状スリーブの周りにマウスピース(2)の内側部(112)が回転可 能に装着されている請求項13がら15のいずれかに記載の吸入器。 18.前記マウスピース(2)の外側部(48)は、その周縁の周りに間隔を置 いて配設された複数の穴(104)を有し、ユーザが吸入すると当該穴を通して 補足空気が引き込まれるようにし、 前記マウスピース(2)の内側部(70)は、少なくとも1つの空気偏向部材 を有し、該空気偏向部材は、前記複数の穴(104)を通して引き込まれた補足 空気が作用するようにした請求項13から17のいずれかに記載の吸入器。 19.前記少なくとも1つの空気偏向部材は、マウスピース(2)の内側部(7 0)の外周面(82)に設けられた複数の縦溝(102)からなり、 前記マウスピース(2)の外側部(48)の複数の穴(104)は、前記マウ スピース(2)の内側部(70)の外周面(82)と対向する関係に配置されて いる請求項18に記載の吸入器。 20.前記縦溝(102)は、前記マウスピース(2)の内側部(70)の回転 軸に平行に整列している請求項19に記載の吸入器。 21.前記縦溝(102)は、前記マウスピース(2)の内側部(70)の回転 軸に対して傾斜している請求項19に記載の吸入器。 22.前記少なくとも1つの空気偏向部材は、前記マウスピース(2)の内側部 (70)の管状部(79)を囲む複数の傾斜ブレード(110)からなる請求項 18に記載の吸入器。 23.前記マウスピース(2)は、少なくとも1つの螺旋状突起(140)が中 に配設された管状部(136)と、前記室(58)の1つの面を形成する半径方 向外方に延びるフランジ(142)とを有し、 前記回転可能部材は、前記室(58)の面を形成する前記フランジ(142) の1つの面の近傍に回転可能に装着されている請求項1から5のいずれかに記載 の吸入器。 24.前記フランジ(142)の下面は、前記室(58)の上面を形成している 請求項23に記載の吸入器。 25.前記フランジ(142)は、前記室(58)の入口と対向して配置されて いる請求項24に記載の吸入器。 26.前記回転可能部材は、ディスク(150)からなる請求項23から25の いずれかに記載の吸入器。 27.前記ディスク(150)は、下方に開口する円錐の形状を有する請求項2 6に記載の吸入器。 28.前記ディスク(150)は、少なくとも1つのほぼ中央に配置された穴 (158)を有する請求項26または27に記載の吸入器。 29.前記ディスク(150)の外周面(155)は、前記室(58)の内周面 と摺動可能に嵌合している請求項26から28のいずれかに記載の吸入器。 30.前記ディスク(150)は、その外周面(155)を規定する下方に垂下 する周縁スカート(154)を有する請求項29に記載の吸入器。 31.前記室(58)は、その周縁の周りに間隔を置いて配設された複数の穴( 104)を有し、ユーザが吸入すると当該穴を通して補足空気が引き込まれるよ うにし、 前記ディスク(150)は、少なくとも1つの空気偏向部材を有し、該空気偏 向部材は、前記複数の穴(104)を通して引き込まれた補足空気が作用するよ うにした請求項29または30に記載の吸入器。 32.前記少なくとも1つの空気偏向部材は、前記ディスク(150)の外周面 (155)に設けられた複数の縦溝(156)からなり、 該複数の穴(104)は、前記ディスク(150)の外周面(155)と対向 する関係に配置されている請求項31に記載の吸入器。 33.前記縦溝(156)は、前記ディスク(150)の回転軸に平行に整列し ている請求項32に記載の吸入器。 34.前記縦溝(102)は、前記ディスク(150)の回転軸に対して傾斜し ている請求項32に記載の吸入器。 35.前記少なくとも1つの空気偏向部材は、前記ディスク(150)の面(1 72)に配設されるとともに、前記室(58)の入口から離れるように向けられ た複数のフィン(174)からなる請求項31に記載の吸入器。 36.前記フィン(174)は、ほぽ半径方向に向けられている請求項35に記 載の吸入器。 37.前記室(58)の入口に対向するディスク(150)の面は、起伏面を有 する請求項26から36の何れかに記載の吸入器。 38.前記起伏面は、整列した凹部からなる請求項37に記載の吸入器。 39.前記起伏面は、整列した凸部からなる請求項37に記載の吸入器。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9700937-7 | 1997-03-14 | ||
SE9700937A SE9700937D0 (sv) | 1997-03-14 | 1997-03-14 | Powder inhaler I |
PCT/SE1998/000465 WO1998041264A1 (en) | 1997-03-14 | 1998-03-13 | Inhalation device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007162777A Division JP2007229523A (ja) | 1997-03-14 | 2007-06-20 | 吸入装置 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2001517984A true JP2001517984A (ja) | 2001-10-09 |
JP2001517984A5 JP2001517984A5 (ja) | 2005-07-14 |
JP4057066B2 JP4057066B2 (ja) | 2008-03-05 |
Family
ID=20406164
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54043198A Expired - Fee Related JP4057066B2 (ja) | 1997-03-14 | 1998-03-13 | 吸入装置 |
JP2007162777A Pending JP2007229523A (ja) | 1997-03-14 | 2007-06-20 | 吸入装置 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007162777A Pending JP2007229523A (ja) | 1997-03-14 | 2007-06-20 | 吸入装置 |
Country Status (21)
Country | Link |
---|---|
US (1) | US6257232B1 (ja) |
EP (1) | EP0979115B1 (ja) |
JP (2) | JP4057066B2 (ja) |
KR (1) | KR100466998B1 (ja) |
CN (1) | CN100500238C (ja) |
AR (1) | AR020247A2 (ja) |
AT (1) | ATE233113T1 (ja) |
AU (1) | AU6431198A (ja) |
BR (1) | BR9808312A (ja) |
CA (1) | CA2283199C (ja) |
DE (1) | DE69811655T2 (ja) |
DK (1) | DK0979115T3 (ja) |
ES (1) | ES2191928T3 (ja) |
HK (1) | HK1029291A1 (ja) |
NO (1) | NO322447B1 (ja) |
NZ (1) | NZ337479A (ja) |
PL (1) | PL188855B1 (ja) |
PT (1) | PT979115E (ja) |
SE (1) | SE9700937D0 (ja) |
WO (1) | WO1998041264A1 (ja) |
ZA (1) | ZA982021B (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009521256A (ja) * | 2005-12-23 | 2009-06-04 | アストラゼネカ・アクチエボラーグ | 新規デバイス |
JP2009528889A (ja) * | 2006-03-03 | 2009-08-13 | エスティーシー.ユーエヌエム | 空力弾性分配メカニズムを有するドライパウダー吸入器 |
JP2010508069A (ja) * | 2006-10-25 | 2010-03-18 | ノバルティス アーゲー | パウダー分散装置、その装置の製造方法および使用方法、その装置および他の装置に使用される構成要素 |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9700938D0 (sv) * | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler II and a method of construction thereof |
TW469832U (en) * | 1997-03-14 | 2001-12-21 | Astra Ab | Inhalation device |
AU761307B2 (en) * | 1997-03-14 | 2003-06-05 | Astra Aktiebolag | Inhalation device |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
PE20010819A1 (es) * | 2000-01-10 | 2001-09-05 | Procter & Gamble | Dispositivo para la inhalacion de polvo seco |
EP1142601B1 (en) * | 2000-04-07 | 2006-02-08 | Andi-Ventis Limited | Mouthpiece for a particulate inhaler |
DK1163920T3 (da) | 2000-06-13 | 2005-02-28 | Andi Ventis Ltd | Mundstykke til en partikelinhalator |
AR028747A1 (es) * | 2000-06-23 | 2003-05-21 | Norton Health Care Ltd | Desaglomerador para inhalador de polvo seco accionado por la respiracion, un inhalador de polvo seco y un metodo de desaglomeracion de polvo seco. |
DE10040528A1 (de) * | 2000-08-18 | 2002-02-28 | Pari Gmbh | Inhalationsvorrichtung und Verfahren zur Erzeugung eines Partikelnebels für Inhalationszwecke |
US6681768B2 (en) * | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
JP3619176B2 (ja) * | 2001-09-14 | 2005-02-09 | オムロンヘルスケア株式会社 | エアロゾル粒子分別装置及び吸入器 |
CA2479751C (en) | 2002-03-20 | 2008-06-03 | Trent Poole | Inhalation apparatus |
GR1004350B (el) * | 2002-03-29 | 2003-09-26 | Συσκευη εισπνοων ξηρης σκονης | |
DE602005024413D1 (de) | 2004-08-20 | 2010-12-09 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
EP2314298B1 (en) | 2004-08-23 | 2015-05-27 | MannKind Corporation | Microparticles comprising diketopiperazine salts for drug delivery |
CA2586886C (en) * | 2004-11-10 | 2013-09-10 | Cipla Limited | Inhaler device |
RU2390325C2 (ru) | 2005-09-14 | 2010-05-27 | Маннкайнд Корпорейшн | Способ приготовления лекарственного препарата, основанный на увеличении сродства активных агентов к поверхностям кристаллических микрочастиц |
DE102006007495A1 (de) | 2006-02-17 | 2007-08-23 | Siegfried Generics International Ag | Dispergiereinheit |
WO2007098500A2 (en) | 2006-02-22 | 2007-08-30 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
KR100638340B1 (ko) * | 2006-03-15 | 2006-10-27 | 송인호 | 낙곡 회수용 흡입기 |
DE102006047667B3 (de) * | 2006-09-28 | 2008-04-24 | Ing. Erich Pfeiffer Gmbh | Inhalationsvorrichtung |
EP2086618A2 (en) * | 2006-11-19 | 2009-08-12 | Aespira Ltd. | Dry-powder inhaler |
RU2501577C2 (ru) * | 2008-05-23 | 2013-12-20 | Оцука Фармасьютикал Ко., Лтд. | Порошковый ингалятор |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
CN101827626B (zh) | 2008-06-13 | 2015-03-18 | 曼金德公司 | 干粉吸入器和用于药物输送的系统 |
JP5479465B2 (ja) | 2008-06-20 | 2014-04-23 | マンカインド コーポレイション | 吸入努力をリアルタイムにプロファイルする対話式機器および方法 |
TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
EP2676695A3 (en) | 2009-03-11 | 2017-03-01 | MannKind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US8734845B2 (en) | 2009-06-12 | 2014-05-27 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
BR112012033060A2 (pt) | 2010-06-21 | 2018-02-27 | Mannkind Corp | métodos de sistema de liberação de fármaco em pó seco |
SG194034A1 (en) | 2011-04-01 | 2013-11-29 | Mannkind Corp | Blister package for pharmaceutical cartridges |
CN102218182B (zh) * | 2011-06-13 | 2015-02-18 | 上海秀新臣邦医药科技有限公司 | 一种干粉给药装置的振动给药装置 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain |
BR112015000529B1 (pt) | 2012-07-12 | 2022-01-11 | Mannkind Corporation | Inalador de pó seco |
WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
KR102499439B1 (ko) | 2013-03-15 | 2023-02-13 | 맨카인드 코포레이션 | 미세결정성 디케토피페라진 조성물 및 방법 |
MX2020009878A (es) | 2013-07-18 | 2022-07-27 | Mannkind Corp | Composiciones farmaceuticas en polvo seco estables al calor y metodos. |
JP2016530930A (ja) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | 通気装置及び方法 |
DE14853999T1 (de) * | 2013-10-15 | 2017-02-16 | Jesse, Ryan Hancock | Verwirbelungsdüse mit steuerbarer geschwindigkeit |
GB201401154D0 (en) * | 2014-01-23 | 2014-03-12 | Team Holdings Uk Ltd | Medical apparatus and method |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
CN104971415B (zh) * | 2015-06-30 | 2020-06-26 | 上海臣邦医药科技股份有限公司 | 一种粉雾剂给药装置的双振动储药单元 |
CN105031782B (zh) * | 2015-06-30 | 2020-06-26 | 上海臣邦医药科技股份有限公司 | 一种提高粉雾剂给药装置加药量计量准确性的方法 |
CN104971411B (zh) * | 2015-06-30 | 2023-08-29 | 上海臣邦医药科技股份有限公司 | 一种粉雾剂给药装置 |
CN104971413B (zh) * | 2015-06-30 | 2023-04-14 | 上海臣邦医药科技股份有限公司 | 一种粉雾剂给药装置的防误操作单元及防误操作方法 |
CN104971412B (zh) * | 2015-06-30 | 2020-06-26 | 上海臣邦医药科技股份有限公司 | 一种粉雾剂给药装置的振动储药单元 |
CN111437473B (zh) * | 2020-04-16 | 2023-03-24 | 宁波诺丁汉大学 | 一种粉雾剂吸入装置 |
US11925749B2 (en) * | 2021-03-18 | 2024-03-12 | Funai Electric Co., Ltd. | Venting of pharmaceutical drug delivery device for air flow and humidity control |
CN115814216A (zh) * | 2022-11-22 | 2023-03-21 | 东莞市中科智恒新材料有限公司 | 一种高性能电子雾化器 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2470296A (en) | 1948-04-30 | 1949-05-17 | Abbott Lab | Inhalator |
US2573918A (en) | 1949-11-05 | 1951-11-06 | Vick Chemical Company | Device for dispensing medicaments |
GB1295081A (en) * | 1969-01-08 | 1972-11-01 | Fisons Pharmaceuticals Ltd | A method and device for dispensing particulate medicament material from a container |
GB1459426A (en) | 1973-02-26 | 1976-12-22 | Allen & Hanburys Ltd | Inhalation devices |
US3948264A (en) | 1975-05-21 | 1976-04-06 | Mead Johnson & Company | Inhalation device |
SE411705B (sv) | 1976-11-09 | 1980-02-04 | Draco Ab | Anordning for generering av en avskermad, vesentligen drivmedelsfri aerosol |
ATE23272T1 (de) | 1981-07-08 | 1986-11-15 | Draco Ab | Pulverinhalator. |
AT384552B (de) | 1985-08-01 | 1987-12-10 | Hurka Wilhelm | Inhalationsgeraet zur dosierung und verteilung von festkoerpern in die atemluft |
SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
US4739754A (en) * | 1986-05-06 | 1988-04-26 | Shaner William T | Suction resistant inhalator |
DE69034007T2 (de) | 1989-04-28 | 2003-05-08 | Riker Laboratories Inc., Northridge | Inhalationsvorrichtung für Trockenpulver |
IT1237118B (it) * | 1989-10-27 | 1993-05-18 | Miat Spa | Inalatore multidose per farmaci in polvere. |
IL111254A (en) | 1990-06-14 | 1998-10-30 | Rhone Poulenc Rorer Ltd | Powder inhalers |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
DE4027391A1 (de) | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgeraet |
AU657492B2 (en) | 1990-09-12 | 1995-03-16 | Hans Bisgaard | An inhaling device |
EP0503031B1 (en) | 1990-09-26 | 1998-04-01 | Pharmachemie B.V. | Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber |
ES2086759T3 (es) | 1991-06-26 | 1996-07-01 | Schering Corp | Dispositivo de inhalacion para medicamentos en polvo. |
RO113214B1 (ro) * | 1992-10-19 | 1998-05-29 | Dura Pharma Inc | Inhalator de pulbere uscata |
EP0668787B1 (en) | 1992-11-12 | 2002-02-27 | Minnesota Mining And Manufacturing Company | Powder inhaler |
AT398277B (de) | 1992-12-11 | 1994-11-25 | Hurka Wilhelm | Inhalationsgerät |
AU683036B2 (en) | 1992-12-18 | 1997-10-30 | Merck Sharp & Dohme Corp. | Inhaler for powdered medications |
EP0692990B1 (en) | 1993-04-06 | 1998-09-23 | Minnesota Mining And Manufacturing Company | Deagglomerators for dry powder inhalers |
US5372128A (en) | 1993-04-14 | 1994-12-13 | Habley Medical Technology Corporation | Fluidizing powder inhaler |
AU1752795A (en) | 1994-03-10 | 1995-09-25 | Franco Del Bon | Inhalator |
GB9419269D0 (en) | 1994-09-23 | 1994-11-09 | Unilever Plc | Aerosol |
-
1997
- 1997-03-14 SE SE9700937A patent/SE9700937D0/xx unknown
-
1998
- 1998-03-10 ZA ZA9802021A patent/ZA982021B/xx unknown
- 1998-03-13 JP JP54043198A patent/JP4057066B2/ja not_active Expired - Fee Related
- 1998-03-13 WO PCT/SE1998/000465 patent/WO1998041264A1/en active IP Right Grant
- 1998-03-13 CA CA002283199A patent/CA2283199C/en not_active Expired - Fee Related
- 1998-03-13 US US09/068,474 patent/US6257232B1/en not_active Expired - Lifetime
- 1998-03-13 CN CNB2006100059833A patent/CN100500238C/zh not_active Expired - Lifetime
- 1998-03-13 AU AU64311/98A patent/AU6431198A/en not_active Abandoned
- 1998-03-13 ES ES98909954T patent/ES2191928T3/es not_active Expired - Lifetime
- 1998-03-13 KR KR10-1999-7008292A patent/KR100466998B1/ko not_active IP Right Cessation
- 1998-03-13 BR BR9808312-0A patent/BR9808312A/pt not_active IP Right Cessation
- 1998-03-13 DK DK98909954T patent/DK0979115T3/da active
- 1998-03-13 NZ NZ337479A patent/NZ337479A/en not_active IP Right Cessation
- 1998-03-13 PT PT98909954T patent/PT979115E/pt unknown
- 1998-03-13 PL PL98335690A patent/PL188855B1/pl unknown
- 1998-03-13 DE DE69811655T patent/DE69811655T2/de not_active Expired - Lifetime
- 1998-03-13 AT AT98909954T patent/ATE233113T1/de active
- 1998-03-13 EP EP98909954A patent/EP0979115B1/en not_active Expired - Lifetime
-
1999
- 1999-08-23 AR ARP990104216A patent/AR020247A2/es active IP Right Grant
- 1999-09-13 NO NO19994434A patent/NO322447B1/no not_active IP Right Cessation
-
2000
- 2000-08-15 HK HK00105086A patent/HK1029291A1/xx not_active IP Right Cessation
-
2007
- 2007-06-20 JP JP2007162777A patent/JP2007229523A/ja active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009521256A (ja) * | 2005-12-23 | 2009-06-04 | アストラゼネカ・アクチエボラーグ | 新規デバイス |
JP2009528889A (ja) * | 2006-03-03 | 2009-08-13 | エスティーシー.ユーエヌエム | 空力弾性分配メカニズムを有するドライパウダー吸入器 |
JP2010508069A (ja) * | 2006-10-25 | 2010-03-18 | ノバルティス アーゲー | パウダー分散装置、その装置の製造方法および使用方法、その装置および他の装置に使用される構成要素 |
US8573197B2 (en) | 2006-10-25 | 2013-11-05 | Novartis Ag | Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices |
US10245394B2 (en) | 2006-10-25 | 2019-04-02 | Mark Glusker | Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices |
Also Published As
Publication number | Publication date |
---|---|
PL188855B1 (pl) | 2005-05-31 |
DK0979115T3 (da) | 2003-05-19 |
US6257232B1 (en) | 2001-07-10 |
ATE233113T1 (de) | 2003-03-15 |
AU6431198A (en) | 1998-10-12 |
EP0979115B1 (en) | 2003-02-26 |
NO322447B1 (no) | 2006-10-09 |
HK1029291A1 (en) | 2001-03-30 |
DE69811655D1 (de) | 2003-04-03 |
JP4057066B2 (ja) | 2008-03-05 |
NO994434D0 (no) | 1999-09-13 |
AR020247A2 (es) | 2002-05-02 |
PT979115E (pt) | 2003-07-31 |
ZA982021B (en) | 1999-12-10 |
CA2283199C (en) | 2007-05-29 |
EP0979115A1 (en) | 2000-02-16 |
SE9700937D0 (sv) | 1997-03-14 |
PL335690A1 (en) | 2000-05-08 |
DE69811655T2 (de) | 2003-12-18 |
KR100466998B1 (ko) | 2005-01-24 |
NO994434L (no) | 1999-11-03 |
CA2283199A1 (en) | 1998-09-24 |
CN100500238C (zh) | 2009-06-17 |
JP2007229523A (ja) | 2007-09-13 |
WO1998041264A1 (en) | 1998-09-24 |
NZ337479A (en) | 2001-05-25 |
BR9808312A (pt) | 2000-05-16 |
KR20000076198A (ko) | 2000-12-26 |
ES2191928T3 (es) | 2003-09-16 |
CN1810312A (zh) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001517984A (ja) | 吸入装置 | |
US6681768B2 (en) | Powder formulation disintegrating system and method for dry powder inhalers | |
CA2445892C (en) | Powder formulation disintegrating system and method for dry powder inhalers | |
KR100906269B1 (ko) | 드라이파우더 흡입기 | |
FI84698B (fi) | Anordning foer finfoerdelning av agglomerat av en enkeldos av ett laekemedelpreparat i pulverform. | |
JP2001506885A (ja) | 粉末吸入器 | |
JP6946363B2 (ja) | 吸入可能な薬剤 | |
JP2005506855A (ja) | 吸入器 | |
JP2001515384A (ja) | 吸引装置 | |
JP2001517980A (ja) | 吸入器 | |
JPH08206207A (ja) | 粉末薬吸入器用の沈降システム | |
JP2002509770A (ja) | 吸入装置 | |
CN109414433A (zh) | 用于吸入的医药组合物 | |
AU761307B2 (en) | Inhalation device | |
WO2002089875A1 (en) | Powder deaggregation device | |
AU2002350483A1 (en) | Powder formulation disintegrating system and method for dry powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041102 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041102 |
|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20041216 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060530 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060830 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061016 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061121 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070220 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070620 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20070816 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20071113 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20071213 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101221 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111221 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121221 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121221 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131221 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |